As the US FDA explores plans to lower the cost of pharmaceuticals with imports from Canada and elsewhere, Sen. Chuck Grassley is calling on the agency to perform more unannounced inspections of foreign facilities. Moving forward, should the administration’s plans to allow certain imports be put into effect, the administration “must require more foreign inspections generally and unannounced inspections specifically, particularly compared to previous administrations,” Grassley writes.  Learn More